搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
9 天
【技术】凯莱英在亚胺还原酶催化合成芦可替尼中间体领域取得重要 ...
近日,凯莱英医药集团(股票代码:002821.SZ/6821.HK,以下简称“凯莱英”)生物合成技术研发中心(CSBT)对亚胺还原酶(IRED)进行筛选和设计改造,获得高活性突变体,实现了酮与水合肼直接反应生成单一手性的肼类化合物。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Secret Service admits failure
Actress Crosby dies at 90
Released after guilty plea
Suns broadcaster dies
Ga. suspect's mom indicted
To skip Al Smith dinner
TN abortion law blocked
CAH sues for trespassing
J&J unit files for bankruptcy
Sesame Place suit verdict
Rejects CNN debate invite
In-person voting begins
SC 1st execution in 13 years
Beirut strike death toll
Bill to boost security OK'd
CA bill to protect kids online
Hand count approved in GA
ISR strike on Gaza school
Feds subpoena Schaeffer
House repeals emission rules
Biden hosts 'Quad' summit
Pandas leaving for China
Sues pharmacy middlemen
144K+ Mavericks recalled
Hiker injured in bear attack
Boeing defense chief exits
WI high court to decide
FDA approves flu vaccine
Drug price challenge revived
1st rabies outbreak in seals
反馈